30 December 2015
Adv. Daniel Green represented Reshef Technologies, an Israeli company, in negotiations with Baharat Electronics, one of India's largest defense companies, for a strategic technology transfer and supply agreement worth tens of millions of dollars.  The transaction also included assistance in establishing a plant in India for assembling electronic fuses for land-based ammunition.
 

Adv. Daniel Green represented Reshef Technologies, an Israeli company, in negotiations with Baharat Electronics, one of India's largest defense companies, for a strategic technology transfer and supply agreement worth tens of millions of dollars.  The transaction also included assistance in establishing a plant in India for assembling electronic fuses for land-based ammunition.
 


01 December 2015
Advs. Daniel Green and Eli Greenbaum represented Oramed Pharmaceuticals, an Israeli clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, in a licensing transaction with Hefei Tianhui Incubator of Technologies Co., Ltd., of China.  The agreement is worth $38 million, with future royalties, and gives HTIT exclusive rights to market Oramed’s oral insulin capsule, in China, Hong Kong and Macau.  This deal is alongside a $12 million equity investment in the company.  

Advs. Daniel Green and Eli Greenbaum represented Oramed Pharmaceuticals, an Israeli clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, in a licensing transaction with Hefei Tianhui Incubator of Technologies Co., Ltd., of China.  The agreement is worth $38 million, with future royalties, and gives HTIT exclusive rights to market Oramed’s oral insulin capsule, in China, Hong Kong and Macau.  This deal is alongside a $12 million equity investment in the company.  


17 August 2014
Advocates Barak S. Platt, Ben Sandler, Ofir Levy, Daniel Green, Eli Greenbaum and Nimrod Vromen represented Clarity Ray, an Israeli startup company developing tools helping publishers and networks identify and prevent ad-fraud, in its acquisition by Yahoo!.
Adv. Kobi Ben Chitrit and Liron Hacohen represented the Company's lead investor, Mr. Saar Wilf.
Clarity Ray's employees will be used by Yahoo! to form its new local R&D hub focusing on internet search frauds. 
 

Advocates Barak S. Platt, Ben Sandler, Ofir Levy, Daniel Green, Eli Greenbaum and Nimrod Vromen represented Clarity Ray, an Israeli startup company developing tools helping publishers and networks identify and prevent ad-fraud, in its acquisition by Yahoo!.
Adv. Kobi Ben Chitrit and Liron Hacohen represented the Company's lead investor, Mr. Saar Wilf.
Clarity Ray's employees will be used by Yahoo! to form its new local R&D hub focusing on internet search frauds. 
 


21 January 2014
Adv. Simon Weintraub lectured at the 6th Plenary Meeting of the European Technology Transfer Offices (TTO) Circle co-organised by the Weizmann Institute of Science and the European Commission’s Joint Research Centre (JRC).

Adv. Simon Weintraub lectured at the 6th Plenary Meeting of the European Technology Transfer Offices (TTO) Circle co-organised by the Weizmann Institute of Science and the European Commission’s Joint Research Centre (JRC).


13 August 2013

Yigal Arnon & Co. represents Johnson & Johnson, Takeda Pharmaceuticals and OrbiMed, to establish a Biotech Incubator

Advocates Barry Levenfeld, Harry Kirsh, Yuval Shalhevet, Zohar Nevo and Noam Enk represents the winning bidding consortium, consisting of Johnson & Johnson, Takeda Pharmaceuticals (the first Japanese Pharmaceutical Company to invest in Israel) and the healthcare fund OrbiMed Israel, for the establishment of an OCS-supported biotechnological incubator intended to encourage the creation and support of pharmaceutical and medical device companies.

Advocates Barry Levenfeld, Harry Kirsh, Yuval Shalhevet, Zohar Nevo and Noam Enk represents the winning bidding consortium, consisting of Johnson & Johnson, Takeda Pharmaceuticals (the first Japanese Pharmaceutical Company to invest in Israel) and the healthcare fund OrbiMed Israel, for the establishment of an OCS-supported biotechnological incubator intended to encourage the creation and support of pharmaceutical and medical device companies.


24 June 2013
Yigal Arnon & Co., in cooperation with IATI, is hosting a Professional Session for start-ups and entrepreneurs on Thursday, July 4, 2013 at 19:00, at TECHLOFT, Tel Aviv  

Yigal Arnon & Co., in cooperation with IATI, is hosting a Professional Session for start-ups and entrepreneurs on Thursday, July 4, 2013 at 19:00, at TECHLOFT, Tel Aviv

 


28 May 2013

Yigal Arnon & Co. represented Aegis as the sole book-running manager for Alcobra Ltd.’s initial public offering on Nasdaq.

Advs. Barry Levenfeld, Eric Spindel, Avigail Frisch and Noam Enk represented Aegis for Alcobra Ltd.'s initial public offering on Nasdaq. Alcobra Ltd., headquartered in Israel, is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug to treat Attention Deficit Hyperactivity Disorder.
 

Advs. Barry Levenfeld, Eric Spindel, Avigail Frisch and Noam Enk represented Aegis for Alcobra Ltd.'s initial public offering on Nasdaq. Alcobra Ltd., headquartered in Israel, is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug to treat Attention Deficit Hyperactivity Disorder.
 


27 December 2012
Yigal Arnon & Co. cooperated with IATI - Israel Advanced Technology Industries in a unique seminar on Employee Compensation for Service Inventions that took place on January 10, 2013 at the TASE.
Adv. Barry Levenfeld lectured at the seminar.

Yigal Arnon & Co. cooperated with IATI - Israel Advanced Technology Industries in a unique seminar on Employee Compensation for Service Inventions that took place on January 10, 2013 at the TASE.
Adv. Barry Levenfeld lectured at the seminar.


Pages

Rankings

Subscribe for updates and news